1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Clinical Significance of Time-to-Surgery and COVID-19 Pandemic in Surgically Treated Non-Small Cell Lung Cancer
- Contribution to journal › Article
- 2024
-
Mark
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
- Contribution to journal › Article
- 2023
-
Mark
A trans-omics assessment of gene–gene interaction in early-stage NSCLC
- Contribution to journal › Article
-
Mark
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis : Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
- Contribution to journal › Article
-
Mark
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
- Contribution to journal › Article
- 2021
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
- Contribution to journal › Article
-
Mark
PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens : A Comparison with Biopsies and Review of the Literature
- Contribution to journal › Article
- 2020
-
Mark
Dna polymerase alpha subunit b is a binding protein for erlotinib resistance in non-small cell lung cancer
- Contribution to journal › Article
- 2018
-
Mark
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
- Contribution to journal › Article
